Broadening horizons with 225 Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177 Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety - Ballal, S; Yadav, M P; Bal, C (European journal of nuclear medicine and molecular imaging, 2019)